{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:38:50Z","timestamp":1758587930503,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.therap.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T01:55:31Z","timestamp":1632275731000},"page":"517-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["1921\u20132021, from insulin to new hypoglycaemic drugs: 100 years of pharmacological research in diabetes mellitus"],"prefix":"10.1016","volume":"76","author":[{"given":"Jean-Louis","family":"Montastruc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.09.002_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.therap.2021.09.003","article-title":"The discovery of hypoglycaemic sulphonamides\u2013Montpellier, 1942","volume":"76","author":"Lavabre-Bertrand","year":"2021","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.002_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.therap.2018.09.074","article-title":"Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes","volume":"74","author":"Salvo","year":"2019","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.002_bib0075","series-title":"Ces m\u00e9dicaments qui ont chang\u00e9 la vie","first-page":"239","author":"Bridel","year":"1985"},{"key":"10.1016\/j.therap.2021.09.002_bib0080","series-title":"La d\u00e9couverte de l\u2019insuline. M\u00e9decine et soci\u00e9t\u00e9s","first-page":"402","author":"Bliss","year":"1988"},{"key":"10.1016\/j.therap.2021.09.002_bib0085","first-page":"363","article-title":"La d\u00e9couverte de l\u2019insuline","volume":"13","author":"Montastruc","year":"1993","journal-title":"Rev Prescr"},{"key":"10.1016\/j.therap.2021.09.002_bib0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.therap.2019.09.004","article-title":"Pharmacovigilance. The next chapter","volume":"74","author":"Moore","year":"2019","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.09.002_bib0095","first-page":"620","article-title":"Sur les possibilit\u00e9s d\u2019un traitement du diab\u00e8te par l\u2019incr\u00e9tine","volume":"12","author":"La Barre","year":"1932","journal-title":"Bull Acad Royal Med Belg"},{"key":"10.1016\/j.therap.2021.09.002_bib0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2018.00387","article-title":"The origin and understanding of the incretin concept","volume":"9","author":"Rehfeld","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.therap.2021.09.002_bib0105","first-page":"285","article-title":"Histoire des incr\u00e9tines\u00a0: du chien brun au monstre de Gila","volume":"10","author":"Schlienger","year":"2016","journal-title":"Med Mal Metab"},{"key":"10.1016\/j.therap.2021.09.002_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.532","article-title":"Phlorizin: a review","volume":"21","author":"Ehrenkranz","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.therap.2021.09.002_bib0115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1172\/JCI112981","article-title":"Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats","volume":"79","author":"Rossetti","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.therap.2021.09.002_bib0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1573406411666150105105529","article-title":"Design of SGLT2 Inhibitors for the treatment of type 2 diabetes: a history driven by biology to chemistry","volume":"11","author":"Cai","year":"2015","journal-title":"Med Chem"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:29Z","timestamp":1758567329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0040595721001803"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1921\u20132021, from insulin to new hypoglycaemic drugs: 100 years of pharmacological research in diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}